Prognosis
Startups Are Hawking Zoloft and Beta-Blockers for Off-Label Uses
The online drug startups Hims and Kick are wading into a legal gray area.
This article is for subscribers only.
To read more about the future of health care, subscribe here to get our Prognosis newsletter delivered to your inbox every Thursday.
A new breed of online health-care startups is testing the boundaries of medical marketing, advertising prescription drugs for unapproved uses to college students with stage fright and men seeking to improve their sexual performance.